405 related articles for article (PubMed ID: 33588102)
1. Stress kinases in the development of liver steatosis and hepatocellular carcinoma.
Cicuéndez B; Ruiz-Garrido I; Mora A; Sabio G
Mol Metab; 2021 Aug; 50():101190. PubMed ID: 33588102
[TBL] [Abstract][Full Text] [Related]
2. Autophagy, NAFLD and NAFLD-Related HCC.
Wu WKK; Zhang L; Chan MTV
Adv Exp Med Biol; 2018; 1061():127-138. PubMed ID: 29956211
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis and non-alcoholic fatty liver diseases.
Kanda T; Matsuoka S; Yamazaki M; Shibata T; Nirei K; Takahashi H; Kaneko T; Fujisawa M; Higuchi T; Nakamura H; Matsumoto N; Yamagami H; Ogawa M; Imazu H; Kuroda K; Moriyama M
World J Gastroenterol; 2018 Jul; 24(25):2661-2672. PubMed ID: 29991872
[TBL] [Abstract][Full Text] [Related]
4. Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease.
Svegliati-Baroni G; Pierantonelli I; Torquato P; Marinelli R; Ferreri C; Chatgilialoglu C; Bartolini D; Galli F
Free Radic Biol Med; 2019 Nov; 144():293-309. PubMed ID: 31152791
[TBL] [Abstract][Full Text] [Related]
5. Hepatoprotective Effect of Loquat Leaf Flavonoids in PM
Jian T; Ding X; Wu Y; Ren B; Li W; Lv H; Chen J
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30275422
[TBL] [Abstract][Full Text] [Related]
6. Deranged hepatocyte intracellular Ca
Ali ES; Rychkov GY; Barritt GJ
Cell Calcium; 2019 Sep; 82():102057. PubMed ID: 31401389
[TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic fatty liver disease and hepatocellular carcinoma.
Zoller H; Tilg H
Metabolism; 2016 Aug; 65(8):1151-60. PubMed ID: 26907206
[TBL] [Abstract][Full Text] [Related]
8. Peroxisomal β-oxidation regulates whole body metabolism, inflammatory vigor, and pathogenesis of nonalcoholic fatty liver disease.
Moreno-Fernandez ME; Giles DA; Stankiewicz TE; Sheridan R; Karns R; Cappelletti M; Lampe K; Mukherjee R; Sina C; Sallese A; Bridges JP; Hogan SP; Aronow BJ; Hoebe K; Divanovic S
JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563328
[TBL] [Abstract][Full Text] [Related]
9. Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice.
Takahara I; Akazawa Y; Tabuchi M; Matsuda K; Miyaaki H; Kido Y; Kanda Y; Taura N; Ohnita K; Takeshima F; Sakai Y; Eguchi S; Nakashima M; Nakao K
PLoS One; 2017; 12(3):e0170591. PubMed ID: 28278289
[TBL] [Abstract][Full Text] [Related]
10. Lactoferrin attenuates fatty acid-induced lipotoxicity via Akt signaling in hepatocarcinoma cells.
Morishita S; Tomita K; Ono T; Murakoshi M; Saito K; Sugiyama K; Nishino H; Kato H
Biochem Cell Biol; 2015 Dec; 93(6):566-73. PubMed ID: 26335364
[TBL] [Abstract][Full Text] [Related]
11. Hepatic Regulator of G Protein Signaling 5 Ameliorates Nonalcoholic Fatty Liver Disease by Suppressing Transforming Growth Factor Beta-Activated Kinase 1-c-Jun-N-Terminal Kinase/p38 Signaling.
Wang J; Ma J; Nie H; Zhang XJ; Zhang P; She ZG; Li H; Ji YX; Cai J
Hepatology; 2021 Jan; 73(1):104-125. PubMed ID: 32191345
[TBL] [Abstract][Full Text] [Related]
12. Chlorogenic acid alleviates autophagy and insulin resistance by suppressing JNK pathway in a rat model of nonalcoholic fatty liver disease.
Yan H; Gao YQ; Zhang Y; Wang H; Liu GS; Lei JY
J Biosci; 2018 Jun; 43(2):287-294. PubMed ID: 29872017
[TBL] [Abstract][Full Text] [Related]
13. Tumor Necrosis Factor α-Induced Protein 8-Like 2 Alleviates Nonalcoholic Fatty Liver Disease Through Suppressing Transforming Growth Factor Beta-Activated Kinase 1 Activation.
Liu Y; Song J; Yang J; Zheng J; Yang L; Gao J; Tian S; Liu Z; Meng X; Wang JC; Dai Z; Tang YD
Hepatology; 2021 Sep; 74(3):1300-1318. PubMed ID: 33768585
[TBL] [Abstract][Full Text] [Related]
14. Insights into the Role of PPARβ/δ in NAFLD.
Chen J; Montagner A; Tan NS; Wahli W
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29954129
[TBL] [Abstract][Full Text] [Related]
15. Elevated levels of circulating ITIH4 are associated with hepatocellular carcinoma with nonalcoholic fatty liver disease: from pig model to human study.
Nakamura N; Hatano E; Iguchi K; Sato M; Kawaguchi H; Ohtsu I; Sakurai T; Aizawa N; Iijima H; Nishiguchi S; Tomono T; Okuda Y; Wada S; Seo S; Taura K; Uemoto S; Ikegawa M
BMC Cancer; 2019 Jun; 19(1):621. PubMed ID: 31238892
[TBL] [Abstract][Full Text] [Related]
16. A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches.
Seki E; Brenner DA; Karin M
Gastroenterology; 2012 Aug; 143(2):307-20. PubMed ID: 22705006
[TBL] [Abstract][Full Text] [Related]
17. Differences in metabolic and liver pathobiology induced by two dietary mouse models of nonalcoholic fatty liver disease.
Zhang H; Léveillé M; Courty E; Gunes A; N Nguyen B; Estall JL
Am J Physiol Endocrinol Metab; 2020 Nov; 319(5):E863-E876. PubMed ID: 32924526
[TBL] [Abstract][Full Text] [Related]
18. Activation of CDK4 Triggers Development of Non-alcoholic Fatty Liver Disease.
Jin J; Valanejad L; Nguyen TP; Lewis K; Wright M; Cast A; Stock L; Timchenko L; Timchenko NA
Cell Rep; 2016 Jul; 16(3):744-56. PubMed ID: 27373160
[TBL] [Abstract][Full Text] [Related]
19. The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Chow MD; Lee YH; Guo GL
Mol Aspects Med; 2017 Aug; 56():34-44. PubMed ID: 28442273
[TBL] [Abstract][Full Text] [Related]
20. Adipocyte JAK2 mediates spontaneous metabolic liver disease and hepatocellular carcinoma.
Corbit KC; Wilson CG; Lowe D; Tran JL; Vera NB; Clasquin M; Mattis AN; Weiss EJ
JCI Insight; 2019 Aug; 5(17):. PubMed ID: 31393852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]